SEC Form 4 · accession 0001681622-18-000020
Varex Imaging Corp · VREX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Carl E. LaCasce
Officer — SVP, Sales & Marketing
Period of report
Jun 5, 2018
Accepted (ET)
Jun 7, 2018 · 5:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001681622
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 5, 2018 | M | 11,155 | $19.21 | A | 27,971 | D | |
| Common StockF2 | Jun 5, 2018 | S | 11,155 | $37.4182 | D | 16,816 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F3 | $19.21 | Jun 5, 2018 | M | 11,155 | D | — | Nov 11, 2018 | Common Stock | 11,155 | 0 | D |
Explanation of responses
- F1Amount of securities beneficially owned at end of reporting period reflect 236 shares purchased on April 27, 2018 under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan.
- F2The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 14, 2018. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.15 to $37.86.
- F3These options were granted in connection with the spin-off from Varian Medical Systems, Inc. and were immediately exercisable because they replaced Varian options that had previously vested.